Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 2,516,202 |
|
|||||
| News | - | ||||||
| Day High | 11.89 | Low High |
|||||
| Day Low | 10.65 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc | EYPT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.62 | 5.54% | 11.82 | 19:53:41 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 11.20 | 10.65 | 11.89 | 11.87 | 11.20 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 27,496 | 2,516,202 | $ 11.21 | $ 28,199,556 | - | 5.67 - 30.99 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:54:36 | 15 | $ 11.70 | USD |
EyePoint Pharmaceuticals (EYPT) Options Flow Summary
EyePoint Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 591.49M | 49.83M | - | 46.02M | -70.8M | -1.42 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
EyePoint Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EYPT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.42 | 21.255 | 10.65 | 13.81 | 2,875,373 | -5.60 | -32.15% |
| 1 Month | 20.64 | 23.645 | 10.65 | 16.17 | 1,507,150 | -8.82 | -42.73% |
| 3 Months | 27.55 | 30.78 | 10.65 | 20.73 | 1,133,860 | -15.73 | -57.10% |
| 6 Months | 7.68 | 30.99 | 5.855 | 19.98 | 1,364,329 | 4.14 | 53.91% |
| 1 Year | 6.54 | 30.99 | 5.67 | 17.03 | 940,662 | 5.28 | 80.73% |
| 3 Years | 9.60 | 30.99 | 2.19 | 14.09 | 532,923 | 2.22 | 23.13% |
| 5 Years | 1.70 | 30.99 | 0.3511 | 7.72 | 650,132 | 10.12 | 595.29% |
EyePoint Pharmaceuticals Description
| EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome Technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. |
